The impact of a pneumococcal vaccination on disease activity in children and adolescents with inflammatory bowel disease: a 2-year prospective study [0.03%]
肺炎球菌疫苗对炎症性肠病患儿疾病活动度的影响：一项为期两年的前瞻性研究
Magdalena Neścioruk,Kinga Kowalska-Duplaga,Urszula Grzybowska-Chlebowczyk et al.
Magdalena Neścioruk et al.
Background: Infectious diseases are known triggers for inflammatory bowel disease (IBD) exacerbations. Although vaccines can prevent many such infections, hesitancy persists among pediatric IBD patients and their caregive...
Multicenter Study
Expert review of vaccines. 2026 Dec;25(1):2652921. DOI:10.1080/14760584.2026.2652921 2026
Interrupted time-series analysis of nationwide surveillance in Thai adult pneumococcal diseases over 14 years: evidence to inform policy in resource-limited countries [0.03%]
长达14年的泰国成人肺炎链球菌病全国监测的中断时间序列分析：资源匮乏国家政策决策的证据支持
Thundon Ngamprasertchai,Anusak Kerdsin,Narisa Ruenroengbun et al.
Thundon Ngamprasertchai et al.
Background: This study aimed to update the incidence and mortality of pneumococcal diseases and to evaluate the population-level trends in pneumococcal diseases incidence in Thailand, following PCV13 licensure and during ...
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25 [0.03%]
2024/25年度欧洲I-MOVE初级保健网络中疫苗对医学上确诊的流感的效果（VEBIS项目）
Héloïse Lucaccioni,Francisco Pozo,Gloria Pérez-Gimeno et al.
Héloïse Lucaccioni et al.
Background: We conducted a multicenter test-negative study to estimate vaccine effectiveness (VE) against medically-attended, laboratory-confirmed influenza in primary care, Europe, 2024/25. ...
Safety of Matrix-M-adjuvanted COVID-19, seasonal influenza, combination influenza-COVID-19, and malaria vaccines: a review of the evidence [0.03%]
矩阵体液抗体辅助新冠肺炎、流感季节性流感联合新冠肺炎-疟疾疫苗的安全性：证据综述
Jonathan Fix,Sandra Lee,Jenny Nachbar et al.
Jonathan Fix et al.
Introduction: The saponin-based Matrix-M adjuvant induces potent and durable immunity through producing long-lasting memory B-cells and broad-based T-cell immunity, across a variety of vaccine platforms. Matrix-M - adjuva...
Addressing RSV infection in older adults: implications for public health policy [0.03%]
老年人呼吸道合胞病毒感染的公共卫生政策应对措施
Floriana D&#x;Ambrosio,Marta Lomazzi,Michael Moore et al.
Floriana D&#x;Ambrosio et al.
Background: The rapid demographic shift toward an aging population presents growing challenges for health systems, particularly preventing infectious diseases. Respiratory syncytial virus (RSV), historically associated wi...
Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study [0.03%]
用于慢性阻塞性肺病患者的RSVPreF3佐剂疫苗接种率和效力：一项全国性丹麦队列研究
Maria João Fonseca,Stanislava Bratković,Yunus Çolak et al.
Maria João Fonseca et al.
Background: Individuals with chronic obstructive pulmonary disease (COPD) face increased risk of severe respiratory syncytial virus (RSV)-related outcomes. We assessed the uptake of adjuvanted-RSVPreF3 vaccine and its eff...
Vaccine hesitancy among 0-6-year-olds' guardians in Chongqing: a cross-sectional survey revealing how immunization program managers' robust comprehensive capacity for adverse events following immunization (AEFI) management mitigates hesitancy [0.03%]
重庆0至6岁儿童监护人群疫苗犹豫现状：一项横断面调查，揭示了免疫规划管理者强大的不良事件应对手段可缓解疫苗犹豫状况
Binyue Xu,Qing Wang,Jiawei Xu et al.
Binyue Xu et al.
Background: Vaccine hesitancy hinders optimal immunization coverage with fear of adverse events following immunization (AEFI) as a key driver. This study examines how robust district-level AEFI management capacity allevia...
Influenza vaccination willingness and influencing factors among older adults in Chongqing China: a cross-sectional study based on the WHO's behavioral and social drivers of vaccination framework [0.03%]
中国重庆市老年人流感疫苗接种意愿及影响因素调查——基于世卫组织疫苗接种行为与社会驱动模型框架的横断面研究
Jule Yang,Shuang Yang,Yu Xiong et al.
Jule Yang et al.
Background: In the context of China's aging population and low influenza vaccine coverage, this study applied the Behavioral and Social Drivers (BeSD) framework to investigate the willingness and determinants of influenza...
Preventing COVID-19 in at-risk populations: moving towards next-generation mRNA-1283 COVID-19 vaccine to address current challenges [0.03%]
预防高风险人群的COVID-19：迈向针对当前挑战的下一代mRNA-1283新冠疫苗
Joseph B Domachowske,Gregory D Zimet,William Hanage et al.
Joseph B Domachowske et al.
Introduction: Next-generation COVID-19 vaccines hold promise to reduce severe outcomes in populations most at risk. While the original mRNA COVID-19 vaccine, mRNA-1273, targets the full-length SARS-CoV-2 spike protein, mR...
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using a COVID-19 vaccine in Costa Rica [0.03%]
在哥斯达黎加使用COVID-19疫苗的接种策略的公共卫生和经济效益及成本效益模型分析
Juan José Baldi-Castro,Carlos Fernando Mendoza,Moe H Kyaw et al.
Juan José Baldi-Castro et al.
Background: Using adapted COVID-19 vaccines targeting current variants in circulation is necessary for addressing the dynamic evolution of the SARS-CoV-2 virus and protecting against emerging variants. ...